AstraZeneca (GB:AZN) has released an update.
AstraZeneca PLC’s CEO, Pascal Soriot, has gifted 297,418 Ordinary Shares to family members at no cost, as disclosed in a compliance notice with market abuse regulations. The transaction, which took place outside of a trading venue on June 10, 2024, signals a notable change in beneficial interest by a key managerial figure within the company. AstraZeneca, a leading biopharmaceutical firm, continues to focus on developing prescription medicines in various therapeutic areas.
For further insights into GB:AZN stock, check out TipRanks’ Stock Analysis page.
